Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.86B | 2.04B | 1.24B | 1.80B | 2.47B | 3.90B | Gross Profit |
976.00M | 940.00M | 864.00M | 1.17B | 1.56B | 1.31B | EBIT |
-42.00M | -47.00M | -144.00M | 89.00M | 340.00M | 376.00M | EBITDA |
-10.75M | 27.00M | -71.00M | 171.00M | 457.00M | 387.00M | Net Income Common Stockholders |
-98.00M | 68.00M | -198.00M | 348.00M | 208.00M | -255.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.08B | 2.19B | 2.77B | 2.96B | 1.85B | 2.10B | Total Assets |
8.39B | 8.64B | 8.36B | 8.43B | 8.90B | 8.30B | Total Debt |
58.00M | 55.00M | 743.00M | 711.00M | 310.00M | 586.00M | Net Debt |
-2.02B | -2.13B | -2.77B | -2.96B | -1.54B | -1.52B | Total Liabilities |
656.00M | 807.00M | 594.00M | 427.00M | 1.25B | 962.00M | Stockholders Equity |
7.73B | 7.83B | 7.77B | 8.01B | 7.66B | 7.35B |
Cash Flow | Free Cash Flow | ||||
0.00 | -409.00M | -217.00M | 729.00M | 188.00M | 2.67B | Operating Cash Flow |
0.00 | -260.00M | -187.00M | 755.00M | 196.00M | 2.69B | Investing Cash Flow |
0.00 | -366.00M | 38.00M | 769.00M | -172.00M | 695.00M | Financing Cash Flow |
0.00 | 43.00M | -45.00M | -364.00M | -276.00M | -2.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥5.95B | 5.95 | 2.90% | 4.57% | -9.09% | ||
76 Outperform | ¥5.38B | 5.63 | 2.57% | 10.18% | 23.95% | ||
74 Outperform | ¥6.09B | 8.99 | 3.31% | 9.95% | 13.53% | ||
69 Neutral | ¥5.22B | 6.98 | 4.20% | 14.83% | 41.81% | ||
61 Neutral | $2.85B | 10.72 | 0.40% | 6.07% | 5.80% | -21.26% | |
58 Neutral | ¥6.88B | 27.06 | ― | 341.55% | -0.36% | ||
55 Neutral | ¥6.20B | 91.17 | 0.29% | 65.02% | ― |